Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Conditions: Hepatorenal Syndrome; Liver Cirrhosis; Acute Kidney Injury; Ascites Hepatic Interventions: Drug: Ambrisentan; Drug: Terlipressin Sponsors: Noorik Biopharmaceuticals AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Find HDV and Determine Its Status in Turkey
Conditions: Chronic Hepatitis D Infection With Hepatitis B Carrier State (Diagnosis); Fibrosis, Liver; Hepatocellular Carcinoma; Cirrhosis, Liver; Transmission Vertical Interventions: Diagnostic Test: Anti Delta Sponsors: Yasar Bay ındır; SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
Conditions: Decompensated Cirrhosis Interventions: Drug: Albumin; Drug: Midodrine; Other: Standard of Care Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Metobolomics in the Characterisation of HE
Conditions: Hepatic Encephalopathy; Cirrhosis Interventions: Diagnostic Test: blood sample Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials

Daily Step Count Using Pedometer for Sarcopenic Management in Patient With Cirrhosis: Randomized Controlled Trial
Conditions: Sarcopenia; Cirrhosis, Liver; Daily Step Count Interventions: Other: Encourage using pedometer; Device: pedometer Sponsors: Mahidol University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials

CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis
Conditions: Decompensated Cirrhosis Interventions: Device: CirrhoCare management system Sponsors: University College, London; CyberLiver Ltd; London School of Hygiene and Tropical Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure
Conditions: Ascites Hepatic; Liver Failure; Cirrhosis, Liver Interventions: Diagnostic Test: Determination of presepsin levels in ascites Sponsors: Carol Davila University of Medicine and Pharmacy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

TIPS for PH Patients: an Observational, Cohort Study
Conditions: Cirrhosis Portal Interventions: Other: No intervention, observational study Sponsors: Nanfang Hospital, Southern Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements
Conditions: Cirrhosis; Vascular Diseases Interventions: Device: Endoscopic ultrasound pressure measurement Sponsors: Institutul Regional de Gastroenterologie& Hepatologie Prof. dr. Octavian Fodor; Universitatea de Medicina si Farmacie Iuliu Hatieganu Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

Hemostasis in Liver Cirrhosis and Hepatocellular Cancer
Conditions: Hemostasis in Decompensated Liver Cirrhosis; Inflammation in Decompensated Liver Cirrhosis Interventions: Diagnostic Test: T-TAS Sponsors: Region Stockholm; Sahlgrenska University Hospital, Sweden Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
DiscussionThis is the first randomised controlled trial comparing two second-line therapies for AIH. Currently, second-line treatment is based on retrospective cohort studies. The rarity of AIH is the main issue in clinical research for alternative treatment options. The results of this trial can be implemented in existing international clinical guidelines.Trial registrationClinicalTrials.govNCT05221411. Retrospectively registered on 3 February 2022; EudraCT number 2021 –003420-33. Prospectively registered on 16 June 2021. (Source: Trials)
Source: Trials - January 17, 2024 Category: Research Source Type: clinical trials

Diagnosis of Adrenal Insufficiency in Liver Cirrhosis Patients
Conditions: Adrenal Insufficiency; Liver Cirrhosis Interventions: Diagnostic Test: rapid ACTH stimulation test Sponsors: Seoul National University Hospital; Korea Institute of Science and Technology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
Conditions: Cirrhosis; Liver Portal Hypertension Interventions: Device: 3D-MRE; Device: HVPG; Device: 2D-MRE; Device: HVPG Sponsors: Shengjing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Early TIPS Improve Survival in Patients With Cirrhosis and Recurrent Ascites: a Multicenter Observational Study
Conditions: Refractory Ascites Interventions: Procedure: transjugular intrahepatic portal shunt Sponsors: Tang-Du Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials

Early Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
Conditions: Refractory Ascites Interventions: Procedure: transjugular intrahepatic portal shunt Sponsors: Tang-Du Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials